Cardiac insulin resistance post-myocardial infarction

Eitemau Tebyg

• The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
  gan: Lygate, C, et al.
  Cyhoeddwyd: (2003)
• Increased uncoupling protein 2 expression in heart failure, but not compensated hypertrophy, post-myocardial infarction
  gan: Murray, A, et al.
  Cyhoeddwyd: (2002)
• Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart.
  gan: Murray, A, et al.
  Cyhoeddwyd: (2006)
• Serial 3D echocardiograhy of postinfarct remodeling in the mouse model of myocardial infarction
  gan: Dawson, D, et al.
  Cyhoeddwyd: (2004)
• nNOS gene deletion exacerbates pathological left ventricular remodelling and functional deterioration after myocardial infarction
  gan: Dawson, D, et al.
  Cyhoeddwyd: (2005)